uMotif
umotif.com
Biotechnology
Clinical Trial Software
Health Care
As featured in
Claim pageClaim
Follow
Overview
Connections
News
Salaries
Products
People
Growth
Offices
Financials
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
AlbionVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Trust, Technology, and the Patient-Site Relationship: Q&A with Andrea Valente, uMotif Applied Clinical Trials Online
In this Q&A, Andrea Valente, CEO of uMotif, discusses what it takes to build genuine trust between patients and sites, why making technology easier to use isn
Read more
Report
uMotif Posts Strong Growth, Earns Market Accolades for eCOA Platform, Demonstrates Continued Clinical Trial Industry Leadership in 2025
Read more
Report
Syneos Health (SYNH) Collaborates With uMotif for New Platform
Syneos Health (SYNH) partners with uMotif to deliver the patient-centric eClinical platform.
Read more
Report
Syneos Health and uMotif Partner to Deliver Patient-centriceClinical Platform
Integrated eCOA & ePRO Solution Taps Company's Decentralized Capabilities and Technology ExpertiseMORRISVILLE, N.C., June 26, 2023 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today
Read more
Report
uMotif - the patient-first data capture and decentralized clinical trials platform - announces $25.5m of new investment from a fund managed by Athyrium Capital Management
Read more
Report
Report